Substituted nucleosides, nucleotides and analogs thereof
AssigneeAlios BioPharma, Inc.
InventorsLeonid Beigelman, Guangyi Wang, David Bernard Smith, Marija Prhavc, Christian Andreas Jekle, Jerome Deval
Life of this patent
Estimating the term…
Abstract
Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Picornavirus and/or Flaviviridae infection with one or more nucleosides, nucleotides and nucleotide analogs.
Claims171
A method for ameliorating or treating a viral infection comprising contacting a cell infected with the virus with an effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt thereof, wherein the compound of Formula (I) has the structure:
- wherein:
- B1A is an optionally substituted heterocyclic base or an optionally substituted heterocyclic base with a protected amino group;
- - - - - - - - - is absent or a single bond, provided that both - - - - - - - - are absent or both - - - - - - - - are a single bond;
- when - - - - - - - - are both absent, then Z1 is absent, O1 is OR1A, R3A is selected from the group consisting of H, halo, OH, —OC(═O)R″A and an optionally substituted O-linked amino acid, R4A is selected from the group consisting of H, OH, halo, N3, —OC(═O)R″B, an optionally substituted O-linked amino acid and NR″B1R″B2, or R3A and R4A are both an oxygen atom connected via a carbonyl to form a 5-membered ring;
- when - - - - - - - - are each a single bond, then Z1 is
- O1 is O, R3A is O;
- R4A is selected from the group consisting of H, OH, halo, N3, —OC(═O)R″B, an optionally substituted O-linked amino acid and NR″B1R″B2;
- and R1B is selected from the group consisting of O−, OH, an —O-optionally substituted C1-6 alkyl.
- an optionally substituted N-linked amino acid and an optionally substituted N-linked amino acid ester derivative;
- Ra1 and Ra2 are independently hydrogen or deuterium;
- RA is hydrogen, deuterium, an unsubstituted C1-3 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-3 alkynyl or cyano;
- R1A is selected from the group consisting of hydrogen, an optionally substituted acyl, an optionally substituted O-linked amino acid,
- R2A is hydrogen, halo, an unsubstituted C1-4 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-4 alkynyl, —CHF2, —(CH2)1-6 halogen, —(CH2)1-6N3, —(CH2)1-6NH2 or —CN;
- R5A is selected from the group consisting of H, halo, OH, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl and an optionally substituted C2-6 alkynyl;
- R6A, R7A and R8A are independently selected from the group consisting of absent, hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl, an optionally substituted C3-6 cycloalkenyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aryl(C1-6 alkyl), an optionally substituted *-(CR15AR16A)p—O—C1-24 alkyl, an optionally substituted *-(CR17AR18A)q—O—C1-24 alkenyl,
- or
- R6A is
- and R7A is absent or hydrogen;
- or
- R6A and R7A are taken together to form a moiety selected from the group consisting of an optionally substituted
- and an optionally substituted
- wherein the oxygens connected to R6A and R7A, the phosphorus and the moiety form a six-membered to ten-membered ring system;
- R9A is independently selected from the group consisting of an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl, an optionally substituted C3-6 cycloalkenyl NR30AR31A an optionally substituted N-linked amino acid and an optionally substituted N-linked amino acid ester derivative;
- R10A and R11A are independently an optionally substituted N-linked amino acid or an optionally substituted N-linked amino acid ester derivative;
- R12A and R13A are independently absent or hydrogen;
- R14A is O−, OH or methyl;
- each R15A, each R16A, each R17A and each R18A are independently hydrogen, an optionally substituted C1-24 alkyl or an alkoxy;
- R19A, R20A, R22A, R23A, R2B, R3B, R5B and R6B are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl and an optionally substituted aryl;
- R21A and R4B are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted aryl, an optionally substituted —O—C1-24 alkyl, an optionally substituted —O-aryl, an optionally substituted —O-heteroaryl and an optionally substituted —O-monocyclic heterocyclyl;
- R24A and R7B are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted aryl, an optionally substituted —O—C1-24 alkyl, an optionally substituted —O-aryl, an optionally substituted —O-heteroaryl, an optionally substituted —O-monocyclic heterocyclyl and
- R25A, R26A, R29A, R8B and R9B are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl and an optionally substituted aryl;
- R27A1 and R27A2 are independently selected from the group consisting of —C≡N, an optionally substituted C2-8 organylcarbonyl, an optionally substituted C2-8 alkoxycarbonyl and an optionally substituted C2-8 organylaminocarbonyl;
- R28A is selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl and an optionally substituted C3-6 cycloalkenyl;
- R30A and R31A are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl, an optionally substituted C3-6 cycloalkenyl and an optionally substituted aryl(C1-4 alkyl);
- R″A and each R″B are independently an optionally substituted C1-24 alkyl;
- each R″B1 and each R″B2 are independently hydrogen and an optionally substituted C1-6 alkyl;
- m is 0 or 1;
- p and q are independently 1, 2 or 3;
- r and s are independently 0, 1, 2 or 3;
- t is 1 or 2;
- u and y can be independently 3, 4 or 5;
- v and w are 1, and
- Z1A, Z2A, Z3A, Z4A, Z1B and Z2B are independently O or S;
- wherein the virus selected from the group consisting of a Picornaviridae virus and a Flaviviridae virus;
- and
- provided that when the Flaviviridae virus is hepatitis C virus, then the compound of Formula (I), or a pharmaceutically acceptable salt thereof, cannot be selected from the group consisting of:
- or a pharmaceutically acceptable salt of the foregoing.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound of Formula (II), or a pharmaceutically acceptable salt thereof, wherein the compound of Formula (II) has the structure:
- wherein:
- B1C is an optionally substituted heterocyclic base or an optionally substituted heterocyclic base with a protected amino group;
- - - - - - - - - is absent or a single bond, provided that both - - - - - - - - are absent or both - - - - - - - - are a single bond;
- when - - - - - - - - are both absent, then Z2 is absent, O2 is OR1C, R3C is selected from the group consisting of H, halo, OH, —OC(═O)R″C and an optionally substituted O-linked amino acid, R4C is selected from the group consisting of H, OH, halo, N3, —OC(═O)R″D, an optionally substituted O-linked amino acid and NR″D1R″D2, or R3C and R4C are both an oxygen atom connected via a carbonyl to form a 5-membered ring;
- when - - - - - - - - are each a single bond, then Z2 is
- O2 is O, R3C is O;
- R4C is selected from the group consisting of OH, halo, N3, —OC(═O)R″D, an optionally substituted O-linked amino acid and NR″D1R″D2;
- and R1D is selected from the group consisting of O−, OH, an —O-optionally substituted C1-6 alkyl,
- an optionally substituted N-linked amino acid and an optionally substituted N-linked amino acid ester derivative;
- Rc1 and Rc2 are independently hydrogen or deuterium;
- RC is hydrogen, deuterium, an unsubstituted C1-3 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-3 alkynyl or cyano;
- R1C is selected from the group consisting of hydrogen, an optionally substituted acyl, an optionally substituted O-linked amino acid,
- R2C is hydrogen, halo, an unsubstituted C1-4 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-4 alkynyl, —CHF2, —(CH2)1-6 halogen, —(CH2)1-6N3, —(CH2)1-6NH2 or —CN;
- R5C is selected from the group consisting of H, halo, OH, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl and an optionally substituted C2-6 alkynyl;
- R6C, R7C and R8C are independently selected from the group consisting of absent, hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl, an optionally substituted C3-6 cycloalkenyl, an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted aryl(C1-6 alkyl), an optionally substituted *-(CR15CR16C)f—O—C1-24 alkyl, an optionally substituted *-(CR17CR18C)g—O—C1-24 alkenyl,
- or
- R6C is
- and R7C is absent or hydrogen;
- or
- R6C and R7C are taken together to form a moiety selected from the group consisting of an optionally substituted
- and an optionally substituted
- wherein the oxygens connected to R6C and R7C, the phosphorus and the moiety form a six-membered to ten-membered ring system;
- R9C is independently selected from the group consisting of an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl, an optionally substituted C3-6 cycloalkenyl, NR30CR31C, an optionally substituted N-linked amino acid and an optionally substituted N-linked amino acid ester derivative;
- R10C and R11C are independently an optionally substituted N-linked amino acid or an optionally substituted N-linked amino acid ester derivative;
- R12C and R13C are independently absent or hydrogen;
- R14C is O—, OH or methyl;
- each R15D, each R16C, each R17C and each R18C are independently hydrogen, an optionally substituted C1-24 alkyl or an alkoxy;
- R19C, R20C, R22C, R23C, R2D, R3D, R5D and R6D are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl and an optionally substituted aryl;
- R21C and R4D are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted aryl, an optionally substituted —O—C1-24 alkyl, an optionally substituted —O-aryl, an optionally substituted —O-heteroaryl and an optionally substituted —O-monocyclic heterocyclyl;
- R24C and R7D are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted aryl, an optionally substituted —O—C1-24 alkyl, an optionally substituted —O-aryl, an optionally substituted —O-heteroaryl, an optionally substituted —O-monocyclic heterocyclyl and
- R25C, R26C, R29C, R8D and R9D are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl and an optionally substituted aryl;
- R27C1 and R27C2 are independently selected from the group consisting of —C≡N, an optionally substituted C2-8 organylcarbonyl, an optionally substituted C2-8 alkoxycarbonyl and an optionally substituted C2-8 organylaminocarbonyl;
- R28C is selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl and an optionally substituted C3-6 cycloalkenyl;
- R30C and R31C are independently selected from the group consisting of hydrogen, an optionally substituted C1-24 alkyl, an optionally substituted C2-24 alkenyl, an optionally substituted C2-24 alkynyl, an optionally substituted C3-6 cycloalkyl, an optionally substituted C3-6 cycloalkenyl and an optionally substituted aryl(C1-4 alkyl);
- R″C and each R″D are independently an optionally substituted C1-24 alkyl;
- each R″D1 and each R″D2 are independently hydrogen or an optionally substituted C1-24 alkyl;
- is 0 or 1,
- f and g are independently 1, 2 or 3;
- h and j are independently 0, 1, 2 or 3;
- b is 1 or 2;
- k and l is independently 3, 4 or 5;
- c and d are 1;
- and
- Z1C, Z2C, Z3C, Z4C, Z1D and Z2D are independently O or S;
- provided that when R2C is halo;
- - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OR1C;
- B1C is selected from the group consisting of an optionally substituted
- an optionally substituted
- an optionally substituted
- an optionally substituted
- an optionally substituted
- and an optionally substituted
- wherein Ra2 is an optionally substituted C1-6 alkyl or an optionally substituted C3-6 cycloalkyl, Ra3 and Ra4 are independently selected from the group consisting of hydrogen, an unsubstituted C1-6 alkyl, an unsubstituted C3-6 alkenyl, an unsubstituted C3-6 alkynyl and an unsubstituted C3-6 cycloalkyl, Ra5 is NHRa8, and Ra6 is hydrogen, halogen or NHRa9;
- Ra7 is NHRa10;
- Ra8 is selected from the group consisting of hydrogen, an optionally substituted C1-6 alkyl, an optionally substituted C3-6 alkenyl, an optionally substituted C3-6 cycloalkyl, —C(═O)Ra11 and —C(═O)ORa12;
- Ra9 is selected from the group consisting of hydrogen, an optionally substituted C1-6 alkyl, an optionally substituted C3-6 alkenyl, an optionally substituted C3-6 cycloalkyl, —C(═O)Ra13 and —C(═O)ORa14;
- Ra10 is selected from the group consisting of hydrogen, an optionally substituted C1-6 alkyl, an optionally substituted C3-6 alkenyl, an optionally substituted C3-6 cycloalkyl, —C(═O)Ra15 and —C(═O)ORa16;
- Xa1 is N or —CRal7;
- Ra17 is selected from the group consisting of hydrogen, halogen, an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl and an optionally substituted C2-6 alkynyl;
- Ra11, Ra12, Ra13, Ra14, R15 and Ra16 are independently selected from the group consisting of C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, C3-6 cycloalkenyl, C6-10 aryl, heteroaryl, heterocyclyl, aryl(C1-6 alkyl), heteroaryl(C1-6 alkyl) and heterocyclyl(C1-6 alkyl);
- then R3C is selected from the group consisting of H, halo and an optionally substituted O-linked amino acid;
- and R4C is selected from the group consisting of OH, halo, N3, —OC(═O)R″D, an optionally substituted O-linked amino acid and NR″D1R″D2;
- or then R3C is selected from the group consisting of H, halo, OH, —OC(═O)R″C and an optionally substituted O-linked amino acid and R4C is an optionally substituted O-linked amino acid;
- or then R1C is
- wherein R6C and R7C are independently
- wherein h is 1, 2 or 3,
- or then R1C is
- wherein R6C and R7C are taken together to form a moiety selected from the group consisting of an optionally substituted
- and an optionally substituted
- wherein the oxygens connected to R6C and R7C, the phosphorus and the moiety form a six-membered to ten-membered ring system;
- provided that when R2C is halo;
- - - - - - - - - are each a single bond;
- then R4C is —OC(═O)R″D or an optionally substituted O-linked amino acid;
- provided that when R2C is an unsubstituted C1-4 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-4 alkynyl, —(CH2)1-6 halogen, —(CH2)1-6N3 or —(CH2)1-6NH2;
- - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OR1C;
- R3C is OH, —OC(═O)R″C or an optionally substituted O-linked amino acid;
- and R4C is halo;
- then R5C is selected from the group consisting of an optionally substituted C1-6 alkyl, an optionally substituted C2-6 alkenyl and an optionally substituted C2-6 alkynyl;
- provided that when R2C is an unsubstituted C1-4 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-4 alkynyl, —(CH2)1-6 halogen, —(CH2)1-6N3 or —(CH2)1-6NH2;
- - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OR1C;
- R4C is halo;
- and R5C is H or halo;
- then R3C is H or halo;
- provided that when R2C is an unsubstituted C1-4 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-4 alkynyl or —(CH2)1-6 halogen;
- - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OR1C;
- R3C is OH, —OC(═O)R″C or an optionally substituted O-linked amino acid;
- R4C is halo;
- R5C is H or halo;
- and R1C is
- then at least one of R6C and R7C is
- wherein R21C is independently selected from the group consisting of an optionally substituted —O-heteroaryl and an optionally substituted —O-monocyclic heterocyclyl;
- or then at least one of R6C and R7C is
- wherein s is 1, 2 or 3;
- or then at least one of R6C and R7C is
- wherein s is 0 and R24C is an optionally substituted —O-heteroaryl or an optionally substituted —O-monocyclic heterocyclyl;
- provided that when R2C is an unsubstituted C1-4 alkyl, an unsubstituted C2-4 alkenyl, an unsubstituted C2-4 alkynyl or —(CH2)1-6 halogen;
- - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OR1C;
- R3C is OH, —OC(═O)R″C or an optionally substituted O-linked amino acid;
- R4C is halo;
- R5C is H or halo;
- and R1C is
- then R8C is
- wherein R21C is independently selected from the group consisting of an optionally substituted —O-heteroaryl and an optionally substituted —O-monocyclic heterocyclyl;
- or then R8C is
- wherein s is 1, 2 or 3;
- or then R8C is
- wherein s is 0 and R24C is an optionally substituted —O-heteroaryl, an optionally substituted —O-monocyclic heterocyclyl or
- provided that when - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OH;
- R2C is methyl;
- R3C is OH;
- then R4C is halo, —OC(═O)R″D or an optionally substituted O-linked amino acid;
- and
- provided that when - - - - - - - - are both absent;
- Z2 is absent;
- O2 is OR1C;
- R2C is fluoro;
- R3C is OH or —OC(═O)R″C;
- R4C is fluoro;
- and R5C is methyl, ethyl or ethenyl;
- then R1C cannot be selected from the group consisting of H,
- wherein R8C is an unsubstituted aryl;
- R9C is
- and Z2 is oxygen.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
The compound of 112, wherein R3C is H or halo.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt of the foregoing.
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt of the foregoing.
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt of the foregoing.
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.